Hasil Pencarian - Devendra Hiwase
- Menampilkan 1 - 7 hasil dari 7
-
1
-
2
P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL oleh David Ross, Devendra Hiwase, Steven Lane, Kirsty Sharplin, Agnes Yong, Yeung David, Dale Chappell, Cameron Durrant, Timothy Hughes, Daniel Thomas
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
3
Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study oleh P. Joy Ho, Devendra Hiwase, Raj Ramakrishna, Nicholas Viiala, Ann Solterbeck, Robert Traficante, Evren Zor, Othon L. Gervasio, Laura M. High, David M. Ross, Donald K. Bowden
Diterbitkan 2019-06-01Dapatkan teks lengkap
Artikel -
4
A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML oleh Anthony P. Schwarer, Jason Butler, Kathryn Jackson, Ashanka Beligaswatte, Louisa Martin, Glen Kennedy, Zantomio Daniela, Ian Lewis, Devendra Hiwase, Joel Wight, Simon He, Andrew Grigg, Kirk Morris, Peter Mollee, Paula Marlton
Diterbitkan 2018-12-01Dapatkan teks lengkap
Artikel -
5
Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia oleh Melita Kenealy, Mark Hertzberg, Warwick Benson, Kerry Taylor, Ilona Cunningham, Will Stevenson, Devendra Hiwase, Richard Eek, Daniela Zantomio, Steve Jong, Meaghan Wall, Piers Blombery, Tracey Gerber, Marlyse Debrincat, Diana Zannino, John F. Seymour
Diterbitkan 2019-04-01Dapatkan teks lengkap
Artikel -
6
Genomics of therapy-related myeloid neoplasms oleh Teodora Kuzmanovic, Bhumika J. Patel, Srinivasa R. Sanikommu, Yasunobu Nagata, Hassan Awada, Cassandra M. Kerr, Bartlomiej P. Przychodzen, Babal K. Jha, Devendra Hiwase, Deepak Singhal, Anjali S. Advani, Aziz Nazha, Aaron T. Gerds, Hetty E. Carraway, Mikkael A. Sekeres, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Tomas Radivoyevitch
Diterbitkan 2020-03-01Dapatkan teks lengkap
Artikel -
7
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial oleh Farhad Ravandi, Gail J. Roboz, Andrew H. Wei, Hartmut Döhner, Christopher Pocock, Dominik Selleslag, Pau Montesinos, Hamid Sayar, Maurizio Musso, Angela Figuera-Alvarez, Hana Safah, William Tse, Sang Kyun Sohn, Devendra Hiwase, Timothy Chevassut, Francesca Pierdomenico, Ignazia La Torre, Barry Skikne, Rochelle Bailey, Jianhua Zhong, C. L. Beach, Herve Dombret
Diterbitkan 2021-08-01Dapatkan teks lengkap
Artikel